Fact · Dictation for work and study
The authors of the palliative medicine pilot state that, because of its small sample size and short study duration, the study is insufficiently powered to draw conclusions about AI scribe benefits in real-world contexts.
Checked against its source on October 17, 2026
In the source's own words
“Given the small sample size and short study duration, this study is insufficiently powered to draw conclusions with respect to AI scribe benefits in real-world contexts.”
Ambient Artificial Intelligence Scribes: A Pilot Survey of Perspectives on the Utility and Documentation Burden in Palliative Medicine, James Patterson et al., Healthcare (Basel), 2025, Discussion.
Open the original (DOI 10.3390/healthcare13172118)- What it measures
- The pilot was a prospective quality improvement study with PDSA cycles at one academic palliative medicine service. It was not randomized.
- What it does not show
- Only the authors' own statement of the study's limits. It does not measure whether the scribe helps in any other clinic.